Page last updated: 2024-11-02

oxybutynin and Respiratory Syncytial Virus Infections

oxybutynin has been researched along with Respiratory Syncytial Virus Infections in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Respiratory Syncytial Virus Infections: Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hervé, PL1
Descamps, D1
Deloizy, C1
Dhelft, V1
Laubreton, D1
Bouguyon, E1
Boukadiri, A1
Dubuquoy, C1
Larcher, T1
Benhamou, PH1
Eléouët, JF1
Bertho, N1
Mondoulet, L1
Riffault, S1

Other Studies

1 other study available for oxybutynin and Respiratory Syncytial Virus Infections

ArticleYear
Non-invasive epicutaneous vaccine against Respiratory Syncytial Virus: Preclinical proof of concept.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, 12-10, Volume: 243

    Topics: Administration, Cutaneous; Animals; Female; Langerhans Cells; Mice; Respiratory Syncytial Virus Infe

2016